DOTI, NUNZIANNA
 Distribuzione geografica
Continente #
AS - Asia 1.991
NA - Nord America 778
EU - Europa 500
SA - Sud America 387
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.694
Nazione #
SG - Singapore 811
US - Stati Uniti d'America 739
CN - Cina 493
BR - Brasile 315
HK - Hong Kong 232
VN - Vietnam 205
IT - Italia 131
FR - Francia 124
KR - Corea 82
NL - Olanda 53
FI - Finlandia 40
DE - Germania 34
GB - Regno Unito 32
JP - Giappone 32
AR - Argentina 30
IN - India 28
CA - Canada 21
BD - Bangladesh 18
PL - Polonia 15
ZA - Sudafrica 15
ID - Indonesia 14
RU - Federazione Russa 14
PY - Paraguay 11
EC - Ecuador 10
IL - Israele 10
IQ - Iraq 10
MX - Messico 10
TR - Turchia 10
SE - Svezia 9
UZ - Uzbekistan 8
CZ - Repubblica Ceca 6
PK - Pakistan 6
UA - Ucraina 6
ES - Italia 5
KE - Kenya 5
NP - Nepal 5
PE - Perù 5
AT - Austria 4
CL - Cile 4
IE - Irlanda 4
NG - Nigeria 4
VE - Venezuela 4
AM - Armenia 3
CO - Colombia 3
JO - Giordania 3
KZ - Kazakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
DM - Dominica 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
RW - Ruanda 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.694
Città #
Singapore 492
Santa Clara 251
Hong Kong 228
Hefei 149
Beijing 91
Lauterbourg 91
Seoul 80
San Jose 76
Ho Chi Minh City 67
Los Angeles 56
Ashburn 46
Hanoi 41
Naples 32
São Paulo 25
Lappeenranta 23
Dallas 21
Frankfurt am Main 20
New York 18
Tokyo 18
Casandrino 17
Helsinki 16
Council Bluffs 13
Amsterdam 12
Shenzhen 11
Da Nang 10
Minamishinagawa 10
Rio de Janeiro 10
Afragola 9
Bengaluru 9
Buffalo 9
Curitiba 9
Haiphong 9
Johannesburg 9
Atlanta 8
Orem 8
Rome 8
Tashkent 8
Asunción 7
Belo Horizonte 7
Brasília 7
Florence 7
Milan 7
Portsmouth 7
Wroclaw 7
Can Tho 6
Phoenix 6
Pozzuoli 6
Prague 6
San Francisco 6
Americana 5
Baghdad 5
Biên Hòa 5
Chicago 5
Dhaka 5
Manchester 5
Montreal 5
Munich 5
Poplar 5
Warsaw 5
Bexley 4
Diadema 4
Elk Grove Village 4
Lấp Vò 4
Nairobi 4
Nha Trang 4
Nuremberg 4
Porto Alegre 4
Santos 4
Stockholm 4
São Bernardo do Campo 4
Vienna 4
Abuja 3
Almaty 3
Amman 3
Bauru 3
Brooklyn 3
Bắc Ninh 3
Dublin 3
Düsseldorf 3
Erbil 3
Gothenburg 3
Guarulhos 3
Guayaquil 3
Jacksonville 3
Livorno 3
Madrid 3
Marseille 3
Montevideo 3
Nam Định 3
Newark 3
Nova Iguaçu 3
Paris 3
Posadas 3
Salvador 3
Shanghai 3
Thành Phố Bà Rịa 3
Varese 3
Yerevan 3
Addis Ababa 2
Aversa 2
Totale 2.272
Nome #
SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection 82
Recent applications of retro-inverso peptides 79
Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy 76
Design, synthesis, structural analysis and biochemical studies of stapled AIF (370-394) analogues as ligand of CypA 74
Targeting Protein-Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches 73
A peptide from the N-terminal region of PED/PEA-15 blocks its interaction with PLD1 and restores insulin sensitivity in skeletal muscle cells . 68
Melittin-Related Peptides Interfere with Sandfly Fever Naples Virus Infection by Interacting with Heparan Sulphate 67
Novel N-Phenyl-Substituted Thiazolidinediones Protect Neural Cells against Glutamate- and tBid-Induced Toxicity 66
A Comprehensive Analysis of the Intrinsic Visible Fluorescence Emitted by Peptide/Protein Amyloid-like Assemblies 65
Design, Optimization, and Structural Characterization of an Apoptosis-Inducing Factor Peptide Targeting Human Cyclophilin A to Inhibit Apoptosis Inducing Factor-Mediated Cell Death 64
Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry 63
Molecular basis of the PED/PEA15 interaction with the C-terminal fragment of phospholipase D1 revealed by NMR spectroscopy 59
Expression, Purification, Structural and Functional Characterization of Recombinant Human Parvulin 17 59
The Characterization of Multifaceted PREP1 Peptides Provides Insights into Correlations between Spectroscopic and Structural Properties of Amyloid-like Assemblies 57
Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine 57
Hylin-a1: A Host Defense Peptide with Antibacterial Potential against Staphylococcus aureus Multi-Resistant Strains 53
Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications-Second Edition 51
Protein-protein interactions and peptide antagonists 50
Synthetic Peptide Libraries. From random mixtures to in vivo testing. 50
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein 50
Design of Three Residues Peptides against SARS-CoV-2 Infection 49
Design and Synthesis of Oligopeptidic Parvulin Inhibitors 49
Oreoch-1: A Peptide from Oreochromis niloticus as a Potential Tool against Staphylococci 48
Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications. 47
Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe 47
A comparative analysis of catalytic activity and stability of microbial transglutaminase in controlled denaturing conditions 47
A recent update on the use of microbial transglutaminase for the generation of biotherapeutics 47
A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cells 46
Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43 46
Hylin-a1: A Pan-Inhibitor against Emerging and Re-Emerging Respiratory Viruses 45
Oreoch‐1: A broad‐spectrum virus and host‐targeting peptide against animal infections 45
Outer Membrane Vesicles Derived from Klebsiella pneumoniae Are a Driving Force for Horizontal Gene Transfer 44
The antiherpetic and anti-inflammatory activity of the frog-derived peptide Hylin-a1 44
Synthetic Frog-Derived-like Peptides: A New Weapon against Emerging and Potential Zoonotic Viruses 44
Expression and purification of the D4 region of PLD1 and characterization of its interaction with PED-PEA15 42
Evaluation of combined use of Oxyma and HATU in aggregating peptide sequences 42
Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells 42
Amyloid-like Prep1 peptides exhibit reversible blue-green-red fluorescence in vitro and in living cells 42
A multianalytical approach to investigate the effect of nanofiltration on plasma-derived factor IX clinical lots 41
FRET-Protease-Coupled Peptidyl-Prolyl cis-trans Isomerase Assay: New Internally Quenched Fluorogenic Substrates for High-Throughput Screening 41
Identification of Inhibitors of Protein-Protein Interactions Through the Screening of Simplified Combinatorial Peptide Libraries. Breaking Away: Proceedings of the 21st American Peptide Symposium Michal Lebl 40
The Interacting Domains of PREP1 and p160 are Endowed with a Remarkable Structural Stability 40
Interleukin 6 reduces vascular smooth muscle cell apoptosis via Prep1 and is associated with aging 40
Selective disruption of insulin-like growth factor (IGF)-1 signalling via phosphoinositide-dependent kinase-1 prevents the protective effect of IGF-1 on human cancer cell death. 39
Monoacylglycerides from the Diatom Skeletonema marinoi Induce Selective Cell Death in Cancer Cells 38
Structural and biochemical insights of CypA and AIF interaction 38
A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cells 38
Discovery ofsmall peptide antagonists of PED/PEA15-D4? interaction from simplifiedcombinatorial libraries 37
The Broad-Spectrum Antiviral Potential of the Amphibian Peptide AR-23 36
Binding mode of AIF(370-394) peptide to CypA: insights from NMR, label-free and molecular docking studies 36
Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy 33
The inhibitory potential of three scorpion venom peptides against multidrug-resistant Klebsiella pnemoniae 33
Relevance and therapeutic potential of CypA targeting to block apoptosis inducing factor-mediated neuronal cell death 32
Peptide antagonists of the PED-hPLD1 binding 32
Peptide mimics of the IgE high affinity receptor Fc?RI?. 31
NMR backbone dynamics studies of human PED/PEA-15 outline protein functional sites 31
Automatic procedures for the synthesis of difficult peptides using oxyma as activating reagent: A comparative study on the use of bases and on different deprotection and agitation conditions 30
Peptide mimics of the IgE high affinity receptor FceRIa 29
Interaction between AIF and CHCHD4 Regulates Respiratory Chain Biogenesis 29
Development and characterization of a membrane-permeant GRASP65-mimetic peptide that inhibits Golgi unlinking and cell cycle progression 29
Residues 762-801 of PLD1 mediate the interaction with PED/PEA15 28
Prep1 regulates angiogenesis through a PGC-1?-mediated mechanism 28
Mapping the native interaction surfaces of PREP1 with PBX1 by cross-linking mass-spectrometry and mutagenesis 28
An analysis of deletion mutants of the PLD1D4 domain defines short regions within the PLD1 interacting with PED/PEA15: implications for the development of peptide specific antagonists. 28
Synthetic peptide ligands for alfa1AT 27
A targeted secretome profiling by multiplexed immunoassay revealed that secreted chemokine ligand 2 (MCP-1/CCL2) affects neural differentiation in mesencephalic neural progenitor cells 27
An analysis of deletion mutants of the PLD1 D4 domain defines short regions within the PLD1 interacting with PED/PEA15: implications for the development of peptides-specific antagonist. 26
Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion 26
Few residues to inhibit VEGF receptors. Chemistry towards 26
Mimetic peptides of suppressor of cytokine signaling (SOCS)1 impair inflammatory responses of epidermal keratinocytes in vitro and in a mouse skin model of allergic contact dermatitis 25
An analysis of deletion mutants of the PLD1 D4 domain defines short regions within the PLD1 interacting with PED/PEA-15: implications for the development of peptides-specific antagonist. 25
An analysis of deletion mutants of the PLD1 D4 domain defines short regions within the PLD1 interacting with PED/PEA15: implications for the development of peptides-specific antagonist 24
Identification of Protease Inhibitors by a Fast Fluorimetric Assay 24
Trifluoroacetylated tyrosine-rich D-tetrapeptides have potent antioxidant activity 24
Expression, purification and characterization of h-Gadd45â 24
Structural versatility of Hepatitis C virus proteins: Implications for the design of novel anti-HCV intervention strategies 23
Peptide antagonists of protein-protein interactions identified by screening protein fragments derived by enzyme degradation 23
Antagonists of Gadd45beta-MKK7 interaction by screening of a synthetic peptide library 23
Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death 22
Peptide Antagonists of Protein-Protein Interactions Identified by Screening Protein Fragments 22
Peptide antagonists of the PED-hPLD1 22
Frog Skin Peptides Hylin-a1, AR-23, and RV-23: Promising Tools Against Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae Infections 21
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment 21
Structure–Function Insights into Frog Skin Peptides Reveal Potent Inhibition of West Nile Virus Entry 21
Synthetic peptide ligands for a1AT 21
Structural analysis of cyclopeptides against VEGF- Receptor A 21
Generation and characterization of monoclonal antibodies against a cyclic variant of hepatitis C virus E2 epitope 412-422 21
Activation of KCNN3/SK3/KCa2.3 channels attenuates enhanced calcium influx and inflammatory cytokine production in activated microglia 21
CHCHD4 Oxidoreductase Activity: A Comprehensive Analysis of the Molecular, Functional, and Structural Properties of Its Redox-Regulated Substrates 21
The Ribosomal Protein L2 Interacts with the RNA Polymerase alpha Subunit and Acts as a Transcription Modulator in Escherichia coli 21
Side Reaction Analysis in Solid-Phase Peptide Synthesis: A Case Study in the Glu–Asp–Tyr Motif 20
Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses 20
Inhibiting the interaction between apoptosis-inducing factor and cyclophilin A prevents brain injury in neonatal mice after hypoxia-ischemia 20
The thiol-disulfide oxidoreductase system in the cold-adapted bacterium Pseudoalteromonas haloplanktis TAC 125: discovery of a novel disulfide oxidoreductase enzyme 19
Discovery of Small Peptide Antagonists of PED/PEA15-D4 alpha Interaction from Simplified Combinatorial Libraries 19
Syntetich peptide ligands for ?1AT 18
Inhibition of the AIF/CypA complex protects against intrinsic death pathways induced by oxidative stress 18
Expression, purification and characterization of Gadd45? 18
Determinants of Chain Selection and Staggering in Heterotrimeric Collagens: A Comprehensive Review of the Structural Data 17
Expanding the Antiviral Spectrum of Scorpion-Derived Peptides Against Toscana Virus and Schmallenberg Virus 17
Totale 3.752
Categoria #
all - tutte 12.600
article - articoli 10.945
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202432 0 0 0 0 0 0 0 0 0 0 23 9
2024/20251.588 11 4 271 61 240 90 8 66 72 111 359 295
2025/20262.287 109 216 238 315 397 161 369 137 141 140 64 0
Totale 3.907